270 related articles for article (PubMed ID: 1602394)
1. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
Imura Y; Stassen JM; Collen D
J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
Imura Y; Stassen JM; Vreys I; Lesaffre E; Gold HK; Collen D
Thromb Haemost; 1992 Sep; 68(3):336-40. PubMed ID: 1440501
[TBL] [Abstract][Full Text] [Related]
3. A technique to investigate microvascular mural thrombus formation in arteries and veins: II. Effects of aspirin, heparin, r-hirudin, and G-4120.
Stockmans F; Stassen JM; Vermylen J; Hoylaerts MF; Nyström A
Ann Plast Surg; 1997 Jan; 38(1):63-8. PubMed ID: 9015542
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of a novel series of aprotinin-derived anticoagulants. II. Comparative antithrombotic effects on primary thrombus formation in vivo.
Stassen JM; Lambeir AM; Vreys I; Deckmyn H; Matthyssens G; Nyström A; Vermylen J
Thromb Haemost; 1995 Aug; 74(2):655-9. PubMed ID: 8585002
[TBL] [Abstract][Full Text] [Related]
5. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
[TBL] [Abstract][Full Text] [Related]
6. Sustained antithrombotic activity of hirudin after its plasma clearance: comparison with heparin.
Agnelli G; Renga C; Weitz JI; Nenci GG; Hirsh J
Blood; 1992 Aug; 80(4):960-5. PubMed ID: 1498336
[TBL] [Abstract][Full Text] [Related]
7. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L
Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304
[TBL] [Abstract][Full Text] [Related]
8. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
[TBL] [Abstract][Full Text] [Related]
9. Combination of a direct thrombin inhibitor and a platelet glycoprotein IIb/IIIa blocking peptide facilitates and maintains reperfusion of platelet-rich thrombus with alteplase.
Sabatine MS; Tu TM; Jang IK
J Thromb Thrombolysis; 2000 Oct; 10(2):189-96. PubMed ID: 11005941
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic activity of argatroban in experimental thrombosis in the rabbit.
Berry CN; Girard D; Girardot C; Lochot S; Lunven C; Visconte C
Semin Thromb Hemost; 1996; 22(3):233-41. PubMed ID: 8836007
[TBL] [Abstract][Full Text] [Related]
11. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition.
Jang IK; Gold HK; Ziskind AA; Leinbach RC; Fallon JT; Collen D
Circulation; 1990 Jan; 81(1):219-25. PubMed ID: 2297828
[TBL] [Abstract][Full Text] [Related]
12. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty.
Meyer BJ; Fernández-Ortiz A; Mailhac A; Falk E; Badimon L; Michael AD; Chesebro JH; Fuster V; Badimon JJ
Circulation; 1994 Nov; 90(5):2474-80. PubMed ID: 7955205
[TBL] [Abstract][Full Text] [Related]
13. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
Agnelli G; Pascucci C; Cosmi B; Nenci GG
Thromb Haemost; 1990 Apr; 63(2):204-7. PubMed ID: 2363121
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy.
Meyer BJ; Badimon JJ; Mailhac A; Fernández-Ortiz A; Chesebro JH; Fuster V; Badimon L
Circulation; 1994 Nov; 90(5):2432-8. PubMed ID: 7955200
[TBL] [Abstract][Full Text] [Related]
15. r-Hirudin inhibits platelet-dependent thrombosis during cardiopulmonary bypass in baboons.
van Wyk V; Neethling WM; Badenhorst PN; Kotzé HF
J Cardiovasc Surg (Torino); 1998 Oct; 39(5):633-9. PubMed ID: 9833724
[TBL] [Abstract][Full Text] [Related]
16. Heparin and the thrombin inhibitor argatroban enhance fibrinolysis by infused or bolus-injected saruplase (r-scu-PA) in rabbit femoral artery thrombosis.
Schneider J
Thromb Res; 1991 Dec; 64(6):677-89. PubMed ID: 1798957
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
[TBL] [Abstract][Full Text] [Related]
18. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
[TBL] [Abstract][Full Text] [Related]
19. Activated clotting time as an appropriate test to compare heparin and direct thrombin inhibitors such as hirudin or Ro 46-6240 in experimental arterial thrombosis.
Carteaux JP; Gast A; Tschopp TB; Roux S
Circulation; 1995 Mar; 91(5):1568-74. PubMed ID: 7867200
[TBL] [Abstract][Full Text] [Related]
20. Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis.
Heras M; Chesebro JH; Webster MW; Mruk JS; Grill DE; Penny WJ; Bowie EJ; Badimon L; Fuster V
Circulation; 1990 Oct; 82(4):1476-84. PubMed ID: 2401076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
